NK-LGL LEUKEMIA
Clinical trials for NK-LGL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new NK-LGL LEUKEMIA trials appear
Sign up with your email to follow new studies for NK-LGL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients as trial tests pill to control resistant cancer
Disease control Recruiting nowThis study is testing an oral medication called golidocitnib for people with slow-growing T/NK-cell lymphomas that have come back or haven't responded to prior treatments. The goal is to see if this once-daily pill can effectively shrink tumors and control the disease. Researcher…
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Old drug gets new shot at fighting rare leukemia
Disease control Recruiting nowThis study is testing whether the drug thalidomide, taken as a pill, can control symptoms of a rare blood cancer called large granular lymphocytic leukemia (LGLL). Researchers want to see if using thalidomide alone works well, based on promising results when it was combined with …
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Massive 8,000-Patient study tracks rare blood cancers for decades
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track 8,000 patients with several rare types of leukemia and lymphoma. It aims to collect health information over many years to understand how these diseases progress, how treatments affect long-term survival, and what late side effe…
Matched conditions: NK-LGL LEUKEMIA
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC